Immunology and Homeopathy. 4. Clinical studies&#8212;part 1 by Bellavite P et al.
Advance Access Publication 5 July 2006 eCAM 2006;3(3)293–301
doi:10.1093/ecam/nel045
Lecture Series
Immunology and Homeopathy. 4. Clinical Studies—Part 1
Paolo Bellavite1, Riccardo Ortolani2, Francesco Pontarollo1, Valeria Piasere1,
Giovanni Benato2 and Anita Conforti3
1Department of Scienze Morfologico-Biomediche, 2Association for Integrative Medicine ‘Giovanni Scolaro’ and
3Department of Medicina e Sanita` Pubblica, University of Verona, Piazza L.A. Scuro, 37134 Verona, Italy
The evidence-based research of the effectiveness of homeopathic medicines in common immunologic
disorders is reviewed. In part 1, we introduce methodological issues of clinical research in homeopathy,
and criteria utilized to evaluate the literature. Then 24 studies (12 randomized and 12 non-randomized)
on common upper respiratory tract infections and otorhinolaryngologic complaints are described. In part
2, the focus will be on allergic diseases and the effectiveness of homeopathy will be globally evaluated
and discussed using the criteria of evidence-based medicine.
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Introduction
Homeopathic research has developed over the past 20 years
with the increasingly greater use of modern medical methods
(clinical trials, observational studies, statistical evaluations,
computerized storage programs and instrumental or laboratory
testing). Over 200 clinical trials designed to verify the efficacy
of homeopathic treatments have been published, many (but not
all) of which have led to positive results. As in other medical
disciplines, statistically significant results could be reached by
pooling all of the methodologically reliable studies in a given
area, but with homeopathy this occurred very rarely, because
few series have been conducted for single conditions and
because the experimental approaches or the medicines used are
too heterogeneous to be able to conclude that any one protocol
is efficacious. Some of these series document clinically useful
effects and differences against placebo (1–5) and some series
do not (6), or their evidence is ‘promising’ but insufficient for
drawing conclusions (7,8).
Recent controversies on the question of whether homeopa-
thy is a placebo response (9–13) have shown that an approved
answer to this dilemma is at present not possible, because
evaluation of the evidence and the inclusion or exclusion of
papers from meta-analyses vary according to pre-selected
criteria, that differ in different reviews, a sort of ‘bias’ of the
observer (14,15). Moreover, there is a noteworthy confusion
concerning what type of ‘homeopathy’ is evaluated (e.g. use of
low or high potencies) and when homeopathy is accused for
its lack of ‘plausibility’ (9,16,17), the different modalities are
not suitably distinguished.
The aim of this lecture series is not to provide a
meta-analysis of homeopathic literature, neither to focus on
the placebo question, themes that have been addressed with
variable results by others (1,9,16,18–26), but to provide an
overview of the best of available homeopathic literature in the
fields of immunoallergology and common inflammatory
diseases. As we have seen in the introductory lecture (27),
immunoallergology represents a bridge between homeopathy
and modern medicine insofar as it is a field in which it is
easier to apply concepts such as the effect of substances
administered on the basis of the logic of the ‘similar’ and the
great sensitivity of living systems to modulations induced by
ultramicrodoses of natural or endogenous substances. In this
field, there is a body of pre-clinical research suggesting that
homeopathic remedies may regulate the immune system at
cellular and/or systemic levels (28–30). There are also pre-
liminary ex vivo observations of significant changes of
immune cells (CD4 lymphocytes) in people treated with high
potencies of homeopathic medicines (31) and, broadly speak-
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immunoregulation by a range of complementary and alterna-
tive medicines (32).
Patients with diseases of the immune system like allergies
and asthma, or with enhanced susceptibility to recurrent infec-
tions, or with rheumatological diseases often have recourse to
homeopathy as ‘alternative’ medicine (33,33–41). Unfortu-
nately, there is paucity of evidence-based recommendations
using homeopathic remedies in these conditions.
Evidence-based medicine will have increasing impact also
in the field of complementary and alternative medicine, but
the systematic evaluation of research evidence in homeopathy
is an expectation that requires suitable methods of evaluation
(42,43). In this new and controversial field, stringency of
tools utilized to systematically evaluate the scientific literature
should always be accompanied by a consensus concerning
clinical protocols that significantly reflect modalities of cure,
types of follow-up and relevance of outcomes, which can be
different from those of conventional medicine. Otherwise
the results, instead of helping the judicious use of evidence
in making clinical decisions, become only the source of
new controversy, especially when disseminated by the
media, as was in the recent Lancet’s meta-analysis that was
inappropriately boosted by the editorial title ‘The end of
homeopathy’(44).
Here, we have distinguished publications in two major
groups, each of which holds a rationale for deployment of
homeopathic remedies. A first group (described in this part of
the review) includes pathologies consisting of anomalous
susceptibility to infections that may be, at least in part, due to
inadequacy of efficiency of the immune system in the rejection
of an extraneous aggressor. The second group (described in a
subsequent part of the review), includes pathologies due to
hypersensitivity of the immune system, the most widespread of
which is immediate hypersensitivity, or allergy, and its major
manifestations at the level of respiratory system. For each
group of pathologies, the different homeopathic methods
utilized, namely (i) classical individualized homeopathy, (ii)
isotherapy, (iii) specific medicines for each disease or
symptom (pluralist or clinical approach) or (iv) complex
formulations (used particularly in homotoxicology) are dealt
with in separately. A general discussion of the evidence-based
homeopathy in these fields will be reported in the second part
of the review.
Analyses
This review reports literature on human subjects available
to us from 1978 to 2006. Principal information sources
were current reading of major CAM journals during the past
15 years, screening of the monthly publication of com-
plementary medicine index (British Library), of the databases
of Central Council for research in Homeopathy and of
Hom-inform Information Service, literature searching using
Medline, CAM on PubMed, Cochrane Database of Systematic
Reviews and CAMbase, cross-referencing. We have also
checked the existing systematic reviews and meta-analyses
that cover trials of immunoallergology. The analysis includes
controlled clinical trials (with and without randomization),
observational studies and case series. All forms of homeo-
pathic intervention are included. That a few published papers,
still unknown to us, escaped from our screening, is conceiv-
able; in any case, we have not made any pre-selection, based
for example on the quality of studies or on their outcomes
(positive versus negative) so that the present review is
certainly representative of the ‘state of the art’ of international
literature in the considered fields.
When complementary and complex interventions such as
acupuncture or homeopathy are considered, there is no
consensus on the quality criteria used to classify the clinical
data according to the importance of treatment outcomes,
the scientific strength and the reliability (11,45,46). Problems
arise especially concerning blinding and concealment,
follow-up indexes particularly in chronic cases, healing
markers, primary and secondary outcomes, and the validity
of experimental versus observational studies. Therefore, to
allow a semi-quantitative ranking of homeopathic treatment
studies, we have adopted the following two criteria.
First, we have classified the publications according to
the type of study, using, with slight modifications, the
classification system that has been developed by the National
Cancer Institute for human studies of complementary and
alternative medicine in cancer studies (http://www.cancer.
gov/cancertopics/pdq/levels-evidence-cam/HealthProfessional/
page2). According to this classification, the score in des-
cending order of strength is reported in Table 1. The main
modification with respect to the NCI classification is that
we have included the randomized (non-blinded) equivalence
studies, comparing two modalities of therapy, in level 1b
and the non-randomized equivalence studies in level 2. Those
types of studies have increasing importance in CAM
literature (47).
A second criterion that may help in ‘weighing’ each
paper is the publication type, which we scored according to a
classification where the top papers are those published in
mainstream medical literature and the last level is provided by
publications in books or conference proceedings (Table 2).
Communications reporting single cases or expert opinions
were excluded. Although this order may be questionable for a
Table 1. Classification of clinical studies in homeopathy
Level of
evidence
Study design
1a Double-blind randomized clinical trials
1b Non-blinded randomized clinical trials, including those
comparing homeopathy with conventional therapy as control
(equivalence studies)
2 Non-randomized controlled clinical trials, including those
comparing homeopathy with conventional therapy (equivalence
studies)
3 Prospective observational studies, without control group
4 Retrospective studies of case series
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number of reasons (especially as concerns the difference
between mainstream and complementary/alternative medicine
journals), we believe that it may facilitate the reader in judging
the grade of evidence provided by each study.
Infections of Upper Airways and
Otorhinolaryngologic Diseases
Homeopathic research in otorhinolaryngology includes studies
of acute and chronic rhinitis, otitis media, sinusitis
and tonsillitis. Here, the diseases of infectious origin are
considered, while the allergic diseases are considered later.
Several homeopathic researchers have worked on these
diseases, which are frequent in the general population, with
often positive results. The unnecessary use of antibiotics in the
initial treatment of acute otitis media and URI is currently
being questioned. Homeopathy has been used historically to
treat this illness, and it is interesting to determine if there are
methodologically rigorous trials to support its effectiveness.
We also report a relevant study on post-chemotherapy
stomatitis, which is caused both by direct mucosal damage
and by infections due to immunodeficiency. We have omitted
the trials on influenza both because of limited space and
existence of recent systematic reviews covering the topic
(26,48). A summary in chronological order is reported
in Table 3 and a brief outline of each protocol with the
main results of different homeopathic strategies is given as
follows.
Classical Individualized Homeopathy
The first report of classical homeopathy is relatively recent,
dating in 1997 when Friese et al. (59) reported an open study
comparing the results obtained treating otitis media in children,
treated using two different medical approaches. They com-
pared classical unitary homeopathic remedies (Aconitum, Apis
mel., Belladonna, Lachesis, Pulsatilla, Silicea, Lycopodium,
Chamomilla and Capsicum) prescribed after an individual
homeopathic case analysis, with conventional therapy based
on antibiotics, mucolytics and antipyretics. The duration of
pain was 2 days in the homeopathic group and 3 days in
the conventional therapy group and the duration of therapy
was 4 and 10 days, respectively. The latter difference was
statistically significant, but it should be noted that the duration
of antibiotic therapy for these conditions cannot be shorter
than a week, so this comparison may not reflect the clinical
outcomes. In brief, this pragmatic study comparing homeo-
pathic with conventional therapy showed that results were
similar, but with a trend in favor of homeopathy.
In an open, prospective, multicenter study, Kruse (60)
evaluated a group of children with otitis media for 6 weeks,
controlling results against conventional therapy. The home-
opathy group was treated with single remedies like Aconitum
30·, Apis 6·, Belladonna 30·, Capsicum 6·, Chamomilla 3·,
Lachesis 12· and other remedies; the reference group was
treated with antibiotics, secretolytics, antipyretics and sym-
pathomimetics such as nasal sprays. In the two groups the
number of children remaining relapse-free and the average
duration of pain were similar.
A Negative Trial and Subsequent Arguments
De Lange de Klerk (62) performed a double-blind, randomized
study that evaluated the frequency, duration and severity of
rhinitis, pharyngitis and tonsillitis in a group of children. The
homeopathic prescription included ‘constitutional’ remedies
for preventive purposes and remedies treating acute phases.
The year-long therapy was continuously adjusted on an
individual basis, and data were collected by means of diaries
kept by parents and attending physicians. Results showed that
homeopathic therapy was slightly but not significantly better
than placebo. The paper was criticized by homeopathic expert
clinicians (73) and methodologists (15) maintaining that
homeopathy in that study required beneficial proof in addition
to conventional therapy. If homeopathy was effective, control
children would require more antibiotics and tonsillectomy, and
this was the case; such surplus of conventional therapies
could have created false negative results.
Observations of Benefit
The purpose of the observational study of Frei and Thurneysen
(64) was to determine how many children with acute otitis
media are relieved of pain with individualized homeopathic
treatment. Children with this condition received a first indi-
vidualized homeopathic medicine in the pediatric office. If
pain reduction was not sufficient after 6 h, a second (different)
homeopathic medicine was given. After a further 6 h, children
who had not reached pain control were started on antibiotics.
Pain control was achieved in 39% of the patients after 6 h,
another 33% after 12 h. Compared with literature’s data, the
authors stated that the resolution rate is 2.4 times faster than in
untreated cases. The six more frequently prescribed remedies
were Pulsatilla, Belladonna, sulphur, phosphorus, calcium
carbonicum, Lycopodium.
An interesting multicenter, prospective, observational study
in a real world medical setting compared the effectiveness of
homeopathy with conventional medicine (65). Thirty investi-
gators with conventional medical licenses at six clinical
sites in four countries enrolled a series of patients with at
least one of the following three complaints: upper respiratory
tract complaints including allergies; lower respiratory tract
complaints including allergies; or ear complaints. Four
Table 2. Classification of publications in homeopathy according to the
type
Class Publication type
1a Mainstream medicine indexed, peer-reviewed, journal
1b Complementary/alternative medicine indexed, peer-reviewed, journal
2 Non-indexed journal
3 Book or book chapter, conference proceedings
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hundred and fifty-six patient visits were compared. In any
case, homeopathy appeared to be at least as effective as
conventional medical care in the treatment of patients with
these three conditions.
A randomized double-blind placebo control pilot study
was conducted (66) in children with otitis media. Subjects
having middle ear effusion and ear pain and/or fever for no
more than 36 h entered into the study. They received either
an individualized homeopathic medicine or a placebo admin-
istered orally three times daily for 5 days, or until symptoms
subsided. There were fewer treatment failures in the group
receiving homeopathy, but these differences were not statis-
tically significant. Diary scores showed a significant decrease
in symptoms after treatment in favor of homeopathy
(P < 0.05).
Controversial Findings
An equivalence trial was performed by Steinsbekk et al. (70),
who investigated whether individualized treatment by home-
opaths is effective in preventing childhood upper respiratory
tract infections (URTI). Children recruited from a group pre-
viously diagnosed with URTI, were randomly assigned to
receive either homeopathic care or to conventional health care.
There was a significant difference in median total symptom
score in favor of homeopathic care compared to the control
group. On the other hand, negative results were obtained by
the same group (71) in a double-blind placebo-controlled
randomized trial. Children with recurrent URTI were ran-
domly assigned to receive either placebo or homeopathic
medicines in 30c potency, chosen by parents using a
simplified constitutional indications for the three medicines
most frequently prescribed by Norwegian homeopaths for this
group of patients (74). When necessary, patients of both
groups were allowed to take conventional medication. There
was no difference in the predefined primary outcome between
the two groups. This can be due to the lack of effect of the
highly diluted homeopathic medicines, to the interference of
conventional treatment, or the process of selection of
medicines, that was performed by parents.
Cost-Effectiveness
A study to compare effectiveness and costs of two treatment
strategies (‘homeopathic strategy’ versus ‘antibiotic strategy’)
used in routine medical practice by allopathic and homeo-
pathic GPs in the treatment of recurrent acute rhinopharyngitis
in children was recently published (72). Data from a large
series of patients were analyzed and grouped according to type
of drug prescribed, episodes of acute rhinopharyngitis,
complications, adverse effects and medical costs. The results
showed that the ‘homeopathic strategy’ yielded significantly
better results than the ‘antibiotic strategy’ in terms of number
of episodes of rhinopharyngitis, number of complications
and quality of life with lower direct medical costs in favor of
homeopathy. Of course, these findings should be confirmed
with randomized studies on homogeneous groups of patients.
Fixed Prescription of Low-Potencies
Although people are best treated with an individualized
homeopathic remedy chosen by a professional homeopath
(75), several trials have found that some common homeopathic
remedies or their combinations may be at least as effective as
conventional medications.
An early study on the effect of a low-dilution homeopathic
medicine on the common cold was done by Gassinger (49).
The authors compared the effect of Eupatorium perfoliatum
2· with that of acetylsalicylic acid. Neither the subjective
symptoms, nor body temperature, nor laboratory data showed
any significant differences in the two groups, which led the
authors to conclude that the homeopathic treatment was as
effective as the allopathic treatment. Of course, this is not a
direct evidence of the efficacy of homeopathy, mostly because
even the effectiveness of analgesic/antipyretic medications in
the common cold is uncertain (76).
Wiesenauer et al. (54) compared the effects of three different
homeopathic treatments and placebo in patients with acute
and chronic sinusitis. In this randomized, double-blind study
the patients were divided into four groups: group A: Luffa
operculata 4· þ Kalium bichromicum 4· þ Cinnabaris 3·;
group B: K. bichromicum 4· þ Cinnabaris 3·; group C:
Cinnabaris 3·; and group D: placebo. The study did not reveal
any difference in therapeutic effects in the four groups. Their
conclusion was that, unless other data emerge from a study of
individual homeopathic prescriptions (‘repertorization’), the
drugs should not be considered active in acute or chronic
sinusitis in the general population; they also pointed out that
similar negative results have been obtained with antibiotics,
nasal decongestants and drainage of the nasal cavities.
Complex Formulations
To cure one or few symptoms, particularly in short-lasting
and acute conditions, complex formulations or mixtures of
homeopathic remedies are often used. The complex homeopa-
thy was born a little after the original discovery of Hahnemann
and it is not fully comparable with homotoxicology which is
a specific methodological way to prescribe complex homeo-
pathic drugs. The latter procedure, also called ‘Biological
medicine’, was developed in the second half of twentieth
century (77,78), starting from Germany. Although homotoxi-
cology is characterized by methods of diagnosis and prescrip-
tion very different from Hahnemann’s original homeopathy,
most of the formulations have their roots in the materia
medica of single components and have the recognition of
‘homeopathic medicines’ by EU drug legislation.
Trials assessing the effectiveness of complex medicines in
relieving specific symptoms are easier to be conducted as
compared with those that require individualized treatment and
continuous adjustment of therapy. Moreover, there is much
higher commercial interest to such formulations than to single
remedies, which cannot be patented. These reasons explain
why there are relatively more studies of complex formulations
than of single homeopathic remedies.
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The primary objective of treating of inflammatory diseases
of upper respiratory tract (rhinitis, uncomplicated sinusitis)
is to relieve obstruction and to improve associated symptoms.
In this respect, a homeopathic remedy may be seen much like
a local decongestant helping restoration of unrestricted
respiration and drainage of nasal sinuses, factors that reduce
the risk of further complications and of chronicity. However,
many homeopathic formulations contain remedies that are
expected to act as immunostimulators and/or according to
isopathic principles of cure.
A homeopathic remedy, L52, a complex formulation con-
taining E. perfoliatum 3·, Aconitum napellus 4·, Bryonia alba
3·, Arnica montana 4·, Gelsemium sempervirens 6·,
Cinchona 4·, Belladonna 4·, Drosera 3·, Senega 3· showed
promising results, in a double-blind study against placebo, for
relief of symptoms of URTI (50), but not in prevention
of flu in a large double-blind, placebo-controlled study
(1200 participants) (79).
In a single-blind randomized trial, army soldiers suffering
from common cold were treated with aspirin or with a complex
homeopathic preparation called Grippheel (Aconitum 4·,
Bryonia 4·, Lachesis 12·, E. perfoliatum 3·, phosphorus 5·)
(52). Comparison between the changes in clinical status and in
subjective disorders on days 4 and 10 and between the
duration of the periods off work in two groups revealed no
significant differences, leading to the conclusion that the two
drugs are equieffective. More recently, the same medicine has
been evaluated in a prospective, observational cohort study in
patients affected by mild viral infections of upper respiratory
tract (68) with encouraging results, consisting of an equivalent
effectiveness of homeopathy and conventional medications.
In the field of respiratory diseases, mention must be made
of a study by some French researchers (51) who treated dry
cough with a syrup based on the plant Drosera and another
nine substances in 3c dilution, and found that it was much
better than placebo: after 1 week of therapy, the symptom had
become less severe or had disappeared in 20 out of 30 treated
patients, as against only 8 out of 30 in placebo group.
Euphorbium
Sprenger (53) conducted an open study of a low-dilution
complex homeopathic preparation, Euphorbium compositum,
used as a nasal spray in patients with acute or chronic rhinitis.
The product consisted of Euphorbium resinifera 4·, Pulsatilla
pratensis 2·, L. operculata 2·, Mercurius iodatus ruber 6·,
Mucosa nasalis suis 6·, Hepar sulphuris calcareum 10·,
Argentum nitricum 10· and Sinusitis nosode 13·, and was
administered at a dose of 1–2 puffs per nostril 3–5 times a day.
The physician’s judgment of the therapy was good in 83% of
cases, whereas tolerability was excellent in 55.4% of cases and
good in 44.6%. Another observational, uncontrolled study on
patients suffering from chronic rhinopathy associated with a
previous long-term application of medication (abuse of nasal
spray) showed positive results in 22 out of 26 patients, with
normalization of rhinomanometric tests (56).
Subsequently, Weiser and Clasen (57) studied the
clinical effectiveness of the same complex E. compositum
in a double-blind, randomized, placebo-controlled study in
subjects with chronic sinusitis. The treated group showed a
significant improvement in terms of subjective symptoms such
as respiratory obstruction, sensation of internal pressure and
pain, but there was no substantial variation in instrumental
tests. An overall evaluation showed a better improvement in
verum group as in placebo group.
A further open, multicenter, prospective, active-controlled
cohort study was carried out more recently on the homeopathic
complex E. compositum (nasal drops), whose effectiveness
and tolerability was compared with the reference allopathic
drug xylometazoline (69). Clinically relevant reductions in
intensities of disease-specific symptoms were observed with
both groups. Non-inferiority of the homeopathic complex
remedy to xylometazoline could be shown for all studied
variables. Tolerability was good for both therapies. Interest-
ingly, it has been reported that some components of this
medicine, e.g. Euphorbium and Pulsatilla, but not Luffa, as
plant extract (not homeopathic preparations), have a direct
antiviral (respiratory syncytial virus and herpes simplex virus
type 1) effect in vitro (80).
Other Low-Dilution Complexes
Zenner and Metelmann (55) published the results of an open
study of a complex preparation, Lymphomyosot drops
(Myosotis arvensis 3·, Veronica officinalis 3·, Teucrium
scorodonia 3·, Pinus sylvestris 4·, and even other 13 plant or
mineral components) in treatment of pharyngitis and tonsilli-
tis. In a group of patients with tonsillitis, most of them
recorded ‘excellent, good or satisfactory’ improvements after
treatments lasting between 1 and 6 months.
A different complex that has been used in this kind of
respiratory complaints is Engystol-N (made of Vincetoxicum
6·, 10· and 30·, sulfur 4· and 10·). A randomized, double-
blind, placebo-controlled trial assessed the efficacy of this
formulation, administered twice weekly as intravenous
injection, for prophylaxis of common cold and flu (58).
The frequency of occurrence of flu or common cold was not
changed by treatments, but the average length of illness and
the severity of symptoms were less for the verum group than
for the placebo group. No statistical analysis of data was
provided.
The efficacy of three plants used in homeopathy to treat
acute tonsillitis was evaluated with an open trial (61). A fixed
combination of low dilutions of three plant substances
(Phytolacca americana, Guajacum officinale and Capsicum
annuum) was used in patients with this condition and
no antibiotics were used. According to materia medica, this
homeopathic complex remedy should be characterized by
immunomodulatory, analgesic and anti-inflammatory proper-
ties. A decrease in objective and subjective symptoms of acute
tonsillitis symptoms was observed after treatment startup;
no serious adverse effects were reported.
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The efficacy and safety of a fixed combination homeopathic
medication (Sinusitis PMD) consisting of Lobaria pulmonaria,
L. operculata and potassium dichromate were investigated in
an open-label practice-based study of patients with acute
sinusitis (63). Most patients received only test medication and
no antibiotics. After 4 days of treatment, secretolysis had
increased significantly and typical sinusitis symptoms, such as
headache, pressure pain at nerve exit points and irritating
cough, were reduced. The average treatment duration was
2 weeks. At the end of treatment, most patients described
themselves as symptom-free or significantly improved.
Adverse drug effects were not reported.
A Remedy for Stomatitis
An Israeli team (67) assessed a complex homeopathic
preparation (Traumeel-S, containing 4·–12· potencies of A.
montana and other plant extracts and minerals) for its effect in
chemotherapy-associated stomatitis, a common consequence
of chemotherapy and a condition for which there is little
effective treatment. The study was conducted in children and
young adults who had undergone stem cell transplantation, in a
randomized, placebo-controlled, double-blind clinical trial.
The medicine was administered as a mouth rinse, five times
daily. Thirty-three percent of patients in active treatment group
did not develop stomatitis, compared with only 7% in placebo
group. Stomatitis worsened in 47% of patients in active
treatment group compared with 93% in placebo group. The
stomatitis scores were better in verum group (P < 0.01). It is
worth noting that, at variance with respect to most homeo-
pathic medicines, the efficacy and the action mechanisms of
Traumeel were repeatedly characterized also in pre-clinical
studies, as described in previous reviews of this series (28,29).
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